Development of an HPLC method for monitoring of Photofrin II therapy

Clinical Biochemistry

Volumn 38, Issue 1, 2005, Pages 73-78

  Vogeser, Michael ^a   Schaffer, Moshe ^a   Egeler, Emil ^a   Spöhrer, Ute ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

HPLC; Photodynamic therapy; Photofrin II; Phototoxicity; Porphyrins; Radiodynamic therapy

Indexed keywords

PHOTOFRIN II; PORPHYRIN; RADIOSENSITIZING AGENT;

ACCURACY; ARTICLE; FLUORESCENCE; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SOLID PHASE EXTRACTION; VALIDATION PROCESS;

ANTINEOPLASTIC AGENTS; CHEMISTRY, ANALYTICAL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DIHEMATOPORPHYRIN ETHER; HUMANS; PHOTOCHEMOTHERAPY; PLASMA; PORPHYRINS; TIME FACTORS;

EID: 10644279310     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2004.09.014     Document Type: Article

References (21)

1. J. McDonald, and T.J. Dougherty Basic principles of photodynamic therapy J. Porphyrins Phthalocyanines 5 2001 105 129
2. C.S. Foot Definition of type I and type II photosensitized oxidation Photochem. Photobiol. 54 1991 659 663
3. G. Jori Tumour photosensitizers: approaches to enhance the efficiency and selectivity of photodynamic therapy J. Photochem. Photobiol., B 36 1996 87 93
4. F. Calzavara, L. Tomio, and L. Corti Oesophageal cancer treated by photodynamic therapy alone or followed by radiation therapy J. Photochem. Photobiol. B. 6 1990 167 174
5. L. Corti, J. Skarlatos, and C. Boso Outcome of patients receiving photodynamic therapy for early oesophageal cancer Int. J. Radiat. Oncol., Biol., Phys. 47 2000 419 424
6. A. Orenstein, G. Kostenich, Y. Roitman, Y. Kopolovic, B. Ehrenberg, and Z. Malik A comparative study of tissue distribution and photodynamic therapy selectivity of chlorin e-6, Photofrin II and ALA-induced protoporphyrin IX in a carcinoma model Br. J. Cancer 73 1996 937 944
7. S. Schwartz, K. Absolon, and H. Vermund Some relationships of porphyrins, X-rays, and tumors Univ. Minn. Med. Bull. 27 1955 7 13
8. L. Cohen, and S. Schwartz Modification of radiosensitivity by porphyrins II. Transplanted rhabdomyosarcoma in mice Cancer Res. 26 1966 1769 1773
9. H. Kostron, M. Shwartz, D.C. Miller, and R. Martuza The interaction of hematoporphyrin derivative, light and ionizing radiation in rat glioma model Cancer 57 1986 964 970
10. T.J. Dougherty Studies on the structure of porphyrins contained in Photofrin II Photochem. Photobiol. 46 1987 569 573
11. C.H. Sun, E. Duzman, J. Mellott, L.H. Liaw, and M.W. Berns Spectroscopic, morphologic, and cytotoxic studies on major fractions of hematoporphyrin derivative and Photofrin II Lasers Surg. Med. 7 1987 171 179
12. C.J. Byrne, L.V. Morshallsay, and A.D. Wand The chemical composition of Photofrin J. Photochem. Photobiol., B. 6 1990 13 27
13. Y.K. Ho, J.R. Missert, and T.J. Dougherty Activity and physicochemical properties of Photofrin Photochem. Photobiol. 54 1991 83 87
14. M. Schaffer, P.M. Schaffer, and L. Corti Photofrin II as an efficient radiosensitizing agent in an experimental tumor Onkologie 24 2001 482 485
15. M. Schaffer, P.M. Schaffer, A. Hofstetter, E. Dühmke, and G. Jori On the double role of Photofrin as a photo- and a radiosensitizing agent: a possible new combination therapy for tumours Photochem. Photobiol. Sci. 1 2002 438 439
16. M. Schaffer, P.M. Schaffer, and L. Corti Radiation therapy combined with Photofrin or 5-ALA-effect on Lewis Sarcoma tumour lines implanted on mice, preliminary results Tumori 88 2002 408 411
17. M. Schaffer, P.M. Schaffer, and L. Corti Photofrin as a specific radiosensitizing agent for tumors: studies in comparison to other porphyrins, in an experimental in vivo mode J. Photochem. Phtotbiol., B. 66 2002 157 164
18. M. Schaffer, P.M. Schaffer, and M. Vogeser Application of Photofrin II as a specific radiosensitizing agent in patients with bladder cancer-A report of two cases Photochem. Photobiol. Sci. 1 2002 686 689
19. M. Schaffer, B. Ertl-Wagner, and P.M. Schaffer Porphyrins as radiosensitizing agents for solid neoplasm Curr. Pharmaceutical Design 9 2003 2024 2035
20. T.J. Dougherty, M.T. Cooper, and T.S. Mang Cutaneous phototoxic occurrences in patients receiving Photofrin Lasers Surg. Med. 10 1990 485 489
21. D.A. Bellnier, W.R. Greco, J.C. Parsons, A.R. Oseroff, A. Kuebler, and T.J. Dougherty An assay for the quantification of Photofrin in tissues and fluids Photochem. Photobiol. 67 1997 237 244